Bio-Buzz Series 01 - USMLE Forums
USMLE Forums Logo
USMLE Forums         Your Reliable USMLE Online Community     Members     Posts
USMLE Articles
Go Back   USMLE Forums > USMLE Step 1 Forum

USMLE Step 1 Forum USMLE Step 1 Discussion Forum: Let's talk about anything related to USMLE Step 1 exam

Thread Tools Search this Thread Display Modes
Old 11-21-2014
Master shifu's Avatar
USMLE Forums Addict
Steps History: Step 1 Only
Posts: 191
Threads: 14
Thanked 87 Times in 59 Posts
Reputation: 97
Default Bio-Buzz Series 01

A 3 year old child present to a pediatrician with restricted joint movement. She is also noted to have coarse facial features and skeletal abnormalities. She is diagnosed with a rare condition and is enrolled in a research study, where a small tissue sample is taken for microscopic examination. On pathologic examination of the specimen, it is noted that there are characteristics inclusion bodies in the cytoplasm of the individual cells. These inclusion bodies stain positive for lysosomal proteins upon immunocytochemistry. Upon receiving the results of the tissue biopsy, the physician explain to the patients mother that her daughter disease is resulting from the aberrant intracellular targeting of proteins.

Which of the following biochemical steps is lacking with this patients??

A) Administration of a transpeptidase that localizes to the trans Golgi

B) Failure of targeting proteins from endocytosis to nucleus

C) Phosphorylation of the mannose residues at Cis Golgi

D) Phosphorylation of the mannose residues at Trans Golgi

E) Phosphorylation of the mannose residues at Endoplasmic reticulum

F) Synthesis of proteins in the rough Endoplasmic reticulum

(Try to Answer with explanation)
We are what we repeatedly do. Excellence, then, is not an act, but a habit.
Reply With Quote Quick reply to this message

Old 11-22-2014
qirkergaard's Avatar
USMLE Forums Veteran
Steps History: Step 1 Only
Posts: 253
Threads: 19
Thanked 129 Times in 98 Posts
Reputation: 139


I-cell disease. If I recall correctly, cis golgi is responsible for targeting M-6-P to molecules that are destined to lysosomes while trans golgi is involved in exocytosis of these targeted molecules.
Reply With Quote Quick reply to this message
The above post was thanked by:
Master shifu (11-23-2014)


Quick Reply

Register Now

In order to be able to post messages on the USMLE Forums forums, you must first register.
Please enter your desired user name, your email address and other required details in the form below.
User Name:
Please enter a password for your user account. Note that passwords are case-sensitive.
Confirm Password:
Email Address
Please enter a valid email address for yourself.
Email Address:
Medical School
Choose "---" if you don't want to tell. AMG for US & Canadian medical schools. IMG for all other medical schools.
USMLE Steps History
What steps finished! Example: 1+CK+CS+3 = Passed Step 1, Step 2 CK, Step 2 CS, and Step 3.

Choose "---" if you don't want to tell.

Favorite USMLE Books
What USMLE books you really think are useful. Leave blank if you don't want to tell.
Where you live. Leave blank if you don't want to tell.


Human Verification

In order to verify that you are a human and not a spam bot, please enter the answer into the following box below based on the instructions contained in the graphic.

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Similar Threads
Thread Thread Starter Forum Replies Last Post
bio rehaf alagha USMLE Step 1 Forum 1 03-03-2014 08:25 AM
cell bio pathophysio1 USMLE Step 1 Forum 1 09-19-2012 09:39 PM
Bio chem Q drgsarunprasath USMLE Step 1 Forum 9 08-15-2011 02:50 AM
Drug bio availability aktorque USMLE Step 1 Forum 11 02-24-2011 09:34 PM
Molecular Bio and Neuro nvme USMLE Step 1 Forum 5 09-10-2009 10:44 AM

RSS Feed
Find Us on Facebook
vBulletin Security provided by vBSecurity v2.2.2 (Pro) - vBulletin Mods & Addons Copyright © 2017 DragonByte Technologies Ltd.

USMLE® & other trade marks belong to their respective owners, read full disclaimer
USMLE Forums created under Creative Commons 3.0 License. (2009-2014)